Cumberland Pharmaceuticals Inc. (CPIX) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Cumberland Pharmaceuticals Inc. (CPIX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Cumberland Pharmaceuticals Inc., analysts forecast revenue rising from $38.23M in 2026 to $44.85M in 2031; the average estimate for 2031 earnings per share is −$0.23; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Cumberland Pharmaceuticals Inc. (CPIX) forecast — frequently asked questions
What are analysts forecasting for Cumberland Pharmaceuticals Inc.'s earnings?
The average analyst estimate for Cumberland Pharmaceuticals Inc. (CPIX) earnings per share in 2031 is -0.23, with individual estimates between -0.23 and -0.23.
How much revenue is Cumberland Pharmaceuticals Inc. expected to make?
Analysts forecast Cumberland Pharmaceuticals Inc. (CPIX) revenue of $44.85M in 2031, based on 1 published estimates.
How many analysts cover CPIX?
1 analyst contribute estimates for Cumberland Pharmaceuticals Inc. (CPIX). Thin coverage makes an average less reliable.
Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.